Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Borgen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1975
Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolismW M Davis, L A Borgen
Journal of Clinical Pharmacology|July 1, 1976
Ripazepam (CI-683): double-blind comparison with placebo in anxious patientsJ J Schneyer, L I Goodman, L A Borgen
The Journal of Clinical Psychiatry|February 1, 1979
Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolyticA Pena-Ramos, C Muniz, L I Goodman, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 12, 1999
Analytical methods and stability assessment of liquid yeast derived sucraseK A McIntosh, S A Charman, L A Borgen, et al.
The Journal of Allergy and Clinical Immunology|June 1, 1985
A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthmaS C Siegel, R M Katz, G S Rachelefsky, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1975
Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolismW M Davis, L A Borgen
Journal of Clinical Pharmacology|July 1, 1976
Ripazepam (CI-683): double-blind comparison with placebo in anxious patientsJ J Schneyer, L I Goodman, L A Borgen
The Journal of Clinical Psychiatry|February 1, 1979
Controlled comparison of trebenzomine with doxepin as an antidepressant-anxiolyticA Pena-Ramos, C Muniz, L I Goodman, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 12, 1999
Analytical methods and stability assessment of liquid yeast derived sucraseK A McIntosh, S A Charman, L A Borgen, et al.
The Journal of Allergy and Clinical Immunology|June 1, 1985
A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthmaS C Siegel, R M Katz, G S Rachelefsky, et al.
Pageof 1